Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elevance HealthELV -1.36%90 3-Year Share Buyback Ratio is 2.50 as of Jun. 2026, which is 25% above its 10-year median of 2.00. GuruFocus rates ELV with a GF Score™ of 90/100 and a GF Value™ of $483.51 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 16 Healthcare Plans companies, Elevance Health ranks better than 68.75% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Elevance Health's current 3-Year Share Buyback Ratio was 2.50%.
The historical rank and industry rank for Elevance Health's 3-Year Share Buyback Ratio or its related term are showing as below:
ELV'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -43.1 Med: 2 Max: 12.2
Current: 2.5
During the past 13 years, Elevance Health's highest 3-Year Share Buyback Ratio was 12.20%. The lowest was -43.10%. And the median was 2.00%.
ELV's 3-Year Share Buyback Ratio is ranked better than 68.75% of 16
companies
in the Healthcare Plans industry
Industry Median: 0.55
vs ELV: 2.50
Elevance Health (NYSE:ELV) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Elevance Health 3-Year Share Buyback Ratio Related Terms
ELV vs CI, CVS, HUM: 3-Year Share Buyback Ratio Comparison
For the Healthcare Plans subindustry, Elevance Health's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health 3-Year Share Buyback Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Elevance Health's 3-Year Share Buyback Ratio falls into.
Elevance Health 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 2.50 mean?
Elevance Health (ELV) has a 3-Year Share Buyback Ratio of 2.50 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Elevance Health and its competitors. This is 25% above median its historical median of 2.00. According to the industry distribution chart, Elevance Health ranks #5 out of 16 companies in the Healthcare Plans industry, placing it in the top 31.2%.
Is Elevance Health's 3-Year Share Buyback Ratio too high?
Elevance Health's current 3-Year Share Buyback Ratio of 2.50 is 25% above median its 10-year median of 2.00. The Healthcare Plans industry median 3-Year Share Buyback Ratio is 0.55. Elevance Health's value of 2.50 is 354.5% above this industry median. Based on the distribution chart, Elevance Health ranks #5 out of 16 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Elevance Health has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's 3-Year Share Buyback Ratio compare to CI and CVS?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #5 out of 16 companies for 3-Year Share Buyback Ratio. This puts Elevance Health in the upper half of its industry. The industry median 3-Year Share Buyback Ratio is 0.55. Elevance Health's value of 2.50 is 354.5% above this benchmark. While the company's 10-year median is 2.00 vs. the industry median of 0.55, Elevance Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Healthcare Plans company?
The median 3-Year Share Buyback Ratio among Healthcare Plans companies is 0.55, based on 16 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Share Buyback Ratio significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current 3-Year Share Buyback Ratio of 2.50 is 354.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Elevance Health and its competitors. For the Healthcare Plans industry, the median 3-Year Share Buyback Ratio is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current 3-Year Share Buyback Ratio is 2.50, which is 25% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is $483.51, compared to a current price of $401.94 — trading 16.9% below its estimated fair value. The current 3-Year Share Buyback Ratio is 2.50, which is 25% above median its 10-year median of 2.00 and 354.5% above the Healthcare Plans industry median of 0.55. Elevance Health's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Elevance Health (ELV), the current 3-Year Share Buyback Ratio is 2.50 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of $401.94 is trading 16.9% below its estimated GF Value™ of $483.51.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for ELV:
3-Year Share Buyback Ratio: 2.50 (25% above median its 10-year median of 2.00)
GF Value™: $483.51 vs. price of $401.94 (16.9% below fair value)
Industry Position: 354.5% above the Healthcare Plans median (#5 of 16)
No single metric tells the full story. See the ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
90GF Score
Get the complete analysis for ELV
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELV has been successfully added to your 
